Results from REACH1, a single-arm phase 2 study of ruxolitinib in combination with corticosteroids for the treatment of steroid-refractory acute graft-vs-host disease Meeting Abstract
| Authors: | Jagasia, M.; Perales, M. A.; Schroeder, M. A.; Ali, H.; Shah, N. N.; Chen, Y. B.; Arbushites, M. C.; Dawkins, F.; Tian, C.; Khoury, H. J. |
| Abstract Title: | Results from REACH1, a single-arm phase 2 study of ruxolitinib in combination with corticosteroids for the treatment of steroid-refractory acute graft-vs-host disease |
| Meeting Title: | 60th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 132 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Dec 1-4 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-11-29 |
| Language: | English |
| ACCESSION: | WOS:000454837601310 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood-2018-99-116342 |
| Notes: | Meeting Abstract: 601 -- Source: Wos |
